An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma : a multicentre, open-label, randomised phase III trial.

Wood, Christopher (author)

Srivastava, Pramod (author)

Bukowski, Ronald (author)

Lacombe, Louis (author)

Gorelov, Andrei I (author)

Gorelov, Sergei (author)

Mulders, Peter (author)

Zielinski, Henryk (author)

Hoos, Axel (author)

Teofilovici, Florentina (author)

Isakov, Leah (author)

Flanigan, Robert (author)

Figlin, Robert (author)

Gupta, Renu (author)

Escudier, Bernard (author)

(creator_code:org_t)

Related links:: http://www.ncbi.nlm....; show more...; https://urn.kb.se/re...; show less...

Subject headings

By the author/editor: Wood, Christophe ...; Srivastava, Pram ...; Bukowski, Ronald; Lacombe, Louis; Gorelov, Andrei ...; Gorelov, Sergei; show more...; Mulders, Peter; Zielinski, Henry ...; Hoos, Axel; Teofilovici, Flo ...; Isakov, Leah; Flanigan, Robert; Figlin, Robert; Gupta, Renu; Escudier, Bernar ...; Ljungberg, Börje; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.